Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients having completed former trials T1001-01 or T1001-02 will undergo one blood sampling for genotyping purposes. In addition they will compete the personality questionnaires they had completed in the former trial.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Unique study arm | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood sampling for genotyping | Genetic | Venous punction of maximum 10 millilitres |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with Single Nucleotide Polymorphisms (SNPs) variation of catechol-O-methyltransferase | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of monoamine oxidase | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of dopamine B hydroxylase | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of dopamine receptor 3 | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of brain-derived neurotropic factor genes | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with SNPs variation of tryptophan hydroxylase-2 | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of 5-hydroxytryptamine transporter |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alvaro Pereira | Tools4Patient | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ATC SA | Liège | 4000 | Belgium | |||
| CIC Clermont-Ferrand CHU G. Montpied |
Not provided
| ID | Term |
|---|---|
| D010523 | Peripheral Nervous System Diseases |
| D010003 | Osteoarthritis |
| D010146 | Pain |
| ID | Term |
|---|---|
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| D005838 | Genotype |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Personality Questionnaires completion |
| Other |
Completion of the following questionnaires: Multidimensional Personality Questionnaire (MPSQ), Interpersonal Reactivity Index (IRI) and Behavioral inhibition system/ Behavioral activation systems (BISBAS) questionnaires |
|
SNPs will be analyzed with Sanger based genotyping or equivalent method
| Time zero equals baseline |
| Number of participants with SNPs variation of 5-hydroxytryptamine receptor 2A | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of serotonin transporter gene-linked polymorphic region genes | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of opioid receptor gene | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Number of participants with SNPs variation of fatty acid amid hydrolase gene | SNPs will be analyzed with Sanger based genotyping or equivalent method | Time zero equals baseline |
| Assessment of Cronbach alpha of the personality questionnaire used in this study and the former ones | Cronbach's alpha between 0 and 1 | Time zero equals baseline |
| Clermont-Ferrand |
| 63003 |
| France |
| Eurofins Optimed | Gières | 38610 | France |
| Institut Curie | Paris | 75005 | France |
| D009140 |
| Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |
| D055614 | Genetic Phenomena |